GenomeWeb

4 days ago | genomeweb.com | Justin Petrone

NEW YORK – ELIXIR this week published a paper in which it calls for new investments in data resources to support European data sovereignty in life sciences research, funding that would both position Europe as a reliable research partner as well as support innovation in artificial intelligence. Such investments could help Europe become less dependent on US funding for shared international resources, some of which have already been impacted as a result of US government cuts.

1 week ago | genomeweb.com | Kelsy Ketchum

NEW YORK – Caris Life Sciences went public this week with the goals of further expanding its customer base and getting closer to profitability, executives said in an interview after the company's stock began trading on the Nasdaq Global Select Market on Wednesday. The firm priced its offering at $21 per share, aiming for gross proceeds of $494.1 million, and its stock price closed on Wednesday up 33 percent at $28.00 per share.

1 week ago | genomeweb.com | Forest Ray

NEW YORK – Methylation patterns found in circulating cell-free DNA (cfDNA) may provide researchers with a finer look at the cell types involved in liver transplant rejection, as well as specific causes of allograft injury. Most current molecular transplant rejection assays monitor transplant health using differences between single-nucleotide polymorphisms (SNPs) found on donor and recipient cfDNA.

1 week ago | genomeweb.com | Forest Ray

NEW YORK – A new computational tool offers a way to efficiently identify protein variations that other methods often overlook, thereby expanding scientists' ability to detect disease-associated mutations. Paul Boutros, professor of urology and human genetics at the University of California, Los Angeles, said that the method, called moPepGen (multi-omics peptide generator), allows researchers to make use of significantly more of the data generated in mass spectrometry experiments.

2 weeks ago | genomeweb.com | Justin Petrone